Key facts
- This page summarizes Kyle Carver's Form 4 filing for Evommune, Inc. (EVMN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Jul 2026, 19:59.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
The purchase by the reporting person reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the sales of 1,000 shares of the Issuer's common stock by the reporting person at the price of $23.42 per share on May 28, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the purchase, $10,160, representing the full amount of the profit realized in connection with the short-swing transaction.